Color Atlas of Pharmacology. (Record no. 17964)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 10080nam a22005053i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC6187166 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240724114240.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2017 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783132411432 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9783132410657 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC6187166 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL6187166 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1153837781 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM301.12 |
| Item number | .L855 2018 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.1 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Lüllmann, Heinz. |
| 245 10 - TITLE STATEMENT | |
| Title | Color Atlas of Pharmacology. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 5th ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Stuttgart : |
| Name of producer, publisher, distributor, manufacturer | Thieme Medical Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2017. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2018. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (446 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Color Atlas of Pharmacology -- At a glance -- Title Page -- Copyright -- Contents -- Preface -- Dedication -- General Pharmacology -- 1 History of Pharmacology -- 1.1 History of Pharmacology -- 2 Drug Sources -- 2.1 Drug and Active Principle -- 2.2 Plants as Sources of Effective Medicines -- 2.3 Human Proteins as Medicines -- 2.4 Drug Development -- 2.5 Drug Benefit Assessment -- 2.6 Congeneric Drugs and Name Diversity -- 3 Drug Administration -- 3.1 Oral Dosage Forms -- 3.2 Drug Administration by Inhalation -- 3.3 Dermatological Agents -- 3.4 Distribution in the Body -- 4 Cellular Sites of Action -- 4.1 Targets of Drug Action -- 5 Distribution in the Body -- 5.1 External Barriers of the Body -- 5.2 Blood-Tissue Barriers -- 5.3 Membrane Permeation -- 5.4 Drug Transporters -- 5.5 Distribution of Drugs -- 5.6 Binding of Drugs to Plasma Proteins -- 6 Drug Elimination -- 6.1 The Liver as an Excretory Organ -- 6.2 Biotransformation of Drugs -- 6.3 Drug Metabolism by CYP -- 6.4 Enterohepatic Circulation -- 6.5 The Kidney as an Excretory Organ -- 6.6 Presystemic Elimination -- 7 Pharmacokinetics -- 7.1 Drug Concentration in the Body -- 7.2 Time Course of Drug Concentration -- 7.3 Time Course during Repeated Dosing -- 7.4 Accumulation -- 8 Quantification of Drug Action -- 8.1 Dose-Response Relationship -- 8.2 Concentration-Effect Relationship -- 8.3 Concentration-Binding Curves -- 9 Drug-Receptor Interaction -- 9.1 Types of Binding Forces -- 9.2 Agonists-Antagonists -- 9.3 Enantioselectivity of Drug Action -- 9.4 Receptor Types -- 9.5 G-Protein-coupled Receptors -- 9.6 Plasma Concentration and Effect -- 10 Adverse Drug Effects -- 10.1 Adverse Drug Effects: Causes -- 10.2 Drug Allergy -- 10.3 Cutaneous Reactions -- 10.4 Pregnancy and Lactation -- 10.5 Genetic Variation of Drug Effects -- 11 Drug-independent Effects -- 11.1 Placebo Therapy. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Systems Pharmacology -- 12 Sympathetic Nervous System -- 12.1 Function of the Sympathetic System -- 12.2 Structure of the Sympathetic Nervous System -- 12.3 Adrenoceptor Subtypes and Catecholamine Actions -- 12.4 Sympathomimetics -- 12.5 Indirect Sympathomimetics -- 12.6 α-Sympathomimetics, α-Sympatholytics -- 12.7 ß-Sympatholytics (ß-blockers) -- 13 Parasympathetic Nervous System -- 13.1 Parasympathetic Functions -- 13.2 Cholinergic Synapse -- 13.3 Parasympathomimetics -- 13.4 Parasympatholytics -- 14 Biogenic Amines -- 14.1 Dopamine -- 14.2 Histamine -- 14.3 Serotonin -- 14.4 Substance P and Amino Acids -- 15 Vasodilators -- 15.1 Vasodilators-Overview -- 15.2 Organic Nitrates -- 15.3 Calcium Antagonists -- 16 Inhibitors of the Renin-Angiotensin-Aldosterone System -- 16.1 ACE Inhibitors -- 17 Drugs Acting on Smooth Muscle -- 17.1 Drugs Acting on Smooth Muscle -- 18 Cardiac Drugs -- 18.1 Cardiac Drugs-Overview -- 18.2 Cardiac Glycosides -- 18.3 Antiarrhythmic Drugs -- 19 Antianemic Agents -- 19.1 Treatment of Anemias -- 19.2 Iron Compounds -- 20 Antithrombotic Agents -- 20.1 Thrombosis Therapy -- 20.2 Vitamin K Antagonists and Vitamin K -- 20.3 Heparin -- 20.4 Fibrinolytics -- 20.5 Inhibitors of Platelet Aggregation -- 21 Plasma Volume Expanders -- 21.1 Plasma Volume Expanders -- 22 Drugs Used in Hyperlipoproteinemias -- 22.1 Lipid-lowering Agents -- 23 Diuretics -- 23.1 Diuretics-Overview -- 23.2 NaCl and Water Reabsorption in the Kidney -- 23.3 Diuretics of the Sulfonamide Type -- 23.4 Potassium-sparing Diuretics and Vasopressin -- 24 Water and Electrolyte Disorders -- 24.1 Water and Electrolyte Disorders -- 25 Gastrointestinal Tract -- 25.1 Treatment of Hyperacidity, Use of Laxatives -- 25.2 Antidiarrheal Agents -- 26 Drugs Affecting the Motor System -- 26.1 Motor System -- 26.2 Muscle Relaxants -- 27 Drugs for the Suppression of Pain (Analgesics). |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 27.1 Nociceptors and Pain Pathways -- 27.2 Eicosanoids -- 27.3 Antipyretic Analgesics -- 27.4 Local Anesthetics -- 27.5 Opioids -- 28 Drugs Acting on the Central Nervous System -- 28.1 General Anesthesia and General Anesthetic Drugs -- 28.2 Inhalational Anesthetics -- 28.3 Injectable Anesthetics -- 28.4 Anxiolytics -- 28.5 Pharmacokinetics of Benzodiazepines -- 28.6 Therapy of Depressive Illness -- 28.7 Therapy of Manic States -- 28.8 Therapy of Schizophrenia -- 29 Drugs Affecting the Endocrine System -- 29.1 Hypothalamic and Hypophyseal Hormones -- 29.2 Thyroid Hormone Therapy -- 29.3 Hyperthyroidism and Antithyroid Drugs -- 29.4 Glucocorticoid Therapy -- 29.5 Androgens, Anabolic Steroids, Antiandrogens -- 29.6 Follicular Growth and Ovulation -- 29.7 Oral Contraceptives -- 29.8 Antiestrogen and Antiprogestin Active Principles -- 29.9 Aromatase Inhibitors -- 29.10 Insulin Formulations -- 29.11 Treatment of Diabetes Mellitus -- 29.12 Type II Diabetes Mellitus -- 29.13 Oral Antidiabetic Drugs -- 29.14 Maintaining Calcium Homeostasis -- 30 Antibacterial Drugs -- 30.1 Drugs for Treating Bacterial Infections -- 30.2 Inhibitors of Cell Wall Synthesis -- 30.3 Pore Formers and Inhibitors of THF Synthesis -- 30.4 Inhibitors of DNA Function -- 30.5 Inhibitors of Protein Synthesis -- 30.6 Drugs for Treating Mycobacterial Infections -- 31 Antifungal Drugs -- 31.1 Drugs Used in the Treatment of Fungal Infections -- 32 Antiviral Drugs -- 32.1 Pharmacotherapy of Viral Infections -- 32.2 Drugs for the Treatment of HIV -- 33 Antiparasitic Drugs -- 33.1 Endo- and Ectoparasites -- 34 Tropical Diseases -- 34.1 Antimalarial Drugs -- 34.2 Other Tropical Diseases -- 35 Anticancer Drugs -- 35.1 Cytostatics -- 35.2 Interference with Cell Proliferation Signaling Pathways -- 35.3 Special Antineoplastic Drug Actions -- 36 Immune Modulators -- 36.1 Inhibition of Immune Responses. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 36.2 Calcineurin Inhibitors, Sirolimus -- 37 Antidotes -- 37.1 Antidotes and Treatment of Poisoning -- 38 "Recreational" Drugs -- 38.1 Psychotomimetics -- 38.2 Tobacco and Nicotine -- 38.3 Consequences of Tobacco Smoking -- 38.4 Alcohol Abuse -- Therapy of Selected Diseases -- 39 Cardiovascular Diseases -- 39.1 Hypertension -- 39.2 Angina Pectoris -- 39.3 Antianginal Drugs -- 39.4 Acute Coronary syndrome-Myocardial Infarction -- 39.5 Congestive Heart Failure -- 39.6 Septic Shock -- 40 Neurological Diseases -- 40.1 Parkinson Disease -- 40.2 Epilepsy -- 40.3 Migraine -- 40.4 Emesis -- 40.5 Sleep Disorders -- 41 Eye Diseases -- 41.1 Glaucoma -- 42 Bone Disorders -- 42.1 Osteoporosis -- 43 Metabolic Disorders -- 43.1 Gout -- 43.2 Obesity -- 44 Immune Disorders -- 44.1 Atopy and Antiallergic Therapy -- 44.2 Bronchial Asthma -- 44.3 COPD -- 44.4 Rheumatoid Arthritis -- 44.5 Chronic Inflammatory Bowel Disease -- 44.6 Multiple Sclerosis -- Further Reading -- 45 Further Reading -- Glossary -- 46 Glossary -- Drug Index -- 47 Drug Index -- 47.1 Antibodies -- 47.2 Kinase Inhibitors -- 47.3 Drug Names → Trade Names -- 47.4 Trade Names → Drug Names -- Abbreviations -- 48 Abbreviations -- Subject Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The Fifth Edition of Luellmann's Color Atlas of Pharmacology has been extensively revised to include all recent advances and new drugs, and the illustrations have been optimized and updated. Each two-page spread presents concise text on the left complemented by detailed full-color illustrations on the right to help users quickly digest important facts and concepts. Color-coded sections provide readers with a helpful framework with which to approach the latest developments in pharmacology. Part 1, General Pharmacology, explains basic aspects, such as drug absorption, distribution, and elimination, along with the molecular mechanisms of drug actions Part 2, Systems Pharmacology, presents the different groups of drugs, emphasizing their functional and therapeutic aspects Part 3, Therapy of Selected Diseases, provides all the relevant information regarding the pharmacological treatment of a large number of conditions Key features: User-friendly format ideal for study and review, self-assessment, and quick reference Completely revised and updated, with 174 color plates New glossary of important and interesting pharmacological terms Updated detailed drug indexes containing current information on drugs listed by both generic and brand names The Fifth Edition of Color Atlas of Pharmacology is an essential study guide and reference for every student, nurse, and practicing physician needing to keep up to date with recent advances in the field. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology--Atlases. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology--Handbooks, manuals, etc. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mohr, Klaus. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hein, Lutz. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Lüllmann, Heinz |
| Title | Color Atlas of Pharmacology |
| Place, publisher, and date of publication | Stuttgart : Thieme Medical Publishers, Incorporated,c2017 |
| International Standard Book Number | 9783132410657 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6187166">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=6187166</a> |
| Public note | Click to View |
No items available.